/
We are a medical technology company focused on developing innovative medical devices that have the potential to improve healthcare. Our primary focus is the sales and marketing of our LuViva Advanced Cervical Scan non-invasive cervical cancer detection device.
The business is unprofitable at the operating level (-309.26% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 10857.1% YoY with margins expanding 29805.0pp.
Negative free cash flow of -$1M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$767K
▲ +10857.1% YoY
Net Income (TTM)
-$3M
▼ -32.2% YoY
Op. Margin
-294.65%
▲ +29805.0pp YoY
ROIC
-358.69%
▲ +263.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$1M
▲ +4.4% YoY
Op. Cash Flow (TTM)
-$1M
▲ +4.6% YoY
Net Debt
$472K
Cash & Equiv.
$369K
5Y CAGR: +49.7%
Continue Research